Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Ossium HPC Marrow, Bone Marrow Transplant
Pre-transplant conditioning - Myeloablative (MAC)
+2 more
Locations
9
United States
City of Hope
Duarte, California, United States
Moffitt Cancer Center
Tampa, Florida, United States
Emory University - Winship Cancer Institute
Atlanta, Georgia, United States
Henry Ford Cancer Institute
Detroit, Michigan, United States
Oregon Health and Science University
Portland, Oregon, United States
TriStar Bone Marrow Transplant
Nashville, Tennessee, United States
Start Date
August 16, 2024
Primary Completion Date
May 31, 2026
Completion Date
March 31, 2027
Last Updated
February 24, 2026
NCT05564390
NCT07320235
NCT06782542
NCT05886049
NCT07523555
NCT07295951
Lead Sponsor
Ossium Health, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions